Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses (CIRCA-HPV)

NAActive, not recruitingINTERVENTIONAL

Enrollment

172

Participants

Timeline

Start Date

January 24, 2019

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions

HPV Positive Pelvic Cancer

Interventions

PROCEDURE

Blood sampling

Patients will have a blood draw at each visit to the hospital and at least 6 months (+/- 1 month) intervals.

Trial Locations (5)

CHU de Besançon, Besançon

CHU Pontchaillou, Rennes

Institut Curie - Paris, Paris

Hôpital Tenon, Paris

Institut Curie - Saint-Cloud, Saint-Cloud

All Listed Sponsors

lead

Institut Curie

OTHER

NCT03739775 - Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses (CIRCA-HPV) | Biotech Hunter | Biotech Hunter